gistic effect in Poe's model. These concentrations are reached in most tissues.
The most difficult fact to reconcile with Poe's proposal is the effect of p- 23 SEPTEMBER 1977 aminobenzoic acid (pABA), which in low concentrations completely eliminates any antibacterial activity of the sulfonamide and any synergism with trimethoprim. We observed that the presence of I ,mg of pABA per milliliter (7.6 x l0-6M) completely suppressed potentiation, leaving unimpaired the activity of trimethoprim. This has also been demonstrated in growth-kinetic experiments (4) . On the other hand, we also found that pABA inhibited by 50 percent the activity of dihydrofolate reductase at a concentration of 1.5 x 10-2M (0.06 mM substrate). Hence, if one assumes that Poe's mechanism is correct, micromolar concentrations of pABA would probably have to replace millimolar concentrations of sulfonamide acting on the dihydrofolate reductase. This remains to be proved.
We conclude that in vitro and in vivo the mechanism proposed by Poe (1) (2) . Earlier reports of behavioral seizures in rats, dogs and monkeys involved the administration of extremely high (often lethal) doses of A9-THC (2) . Exceptions to the latter findings are the behavioral convulsions in our rabbits and the myoclonus (and EEG spiking) in Feeney's epileptic beagle dogs (3) elicited by A9-THC; we suggest that both these effects are novel and are probably strain-specific or at least strain-sensitive responses. However, while the epileptic beagle dog shows "spontaneous" behavioral convulsions, no "spontaneous" convulsions have ever been observed in our rabbits or, to our knowledge, in any rabbits. Genetically inbred audiogenic rabbits have been described (5), but sound, light, and tactile stimuli do not cause seizures in our rabbits (2); indeed, the only behavioral convulsions we have observed are those which reliably and immediately follow injection of psychoactive cannabinoids. Furthermore, the median convulsant dose of A9-THC in our rabbits is very low, that is, 0.05 mg/kg, given intravenously (6) . This dose is far below the median lethal dose, that is, 155 mg/kg, reported for "normal" rabbits (7) and below the highest dose we have given to our rabbits, that is, 12 mg/kg, which was not lethal. Indeed, the lowest doses that elicit convulsions in our rabbits are comparable to those producing psychoactive effects in humans. Since the intravenous route of administration produces quantitative effects similar to the inhalational route for active marihuana ingredients (8) , and the mean inhalation dose for the human is 0.1 mg/kg (9) Feeney's second point is that behavioral convulsions are not due to the stimulant action of cannabinoids since the stimulant drug methamphetamine does not produce convulsions. This reasoning assumes that the cannabinoids and methamphetamines have the same mechanism of action; however, there are not enough data to warrant such speculation.
While it is difficult to extrapolate data across species. it is possible that marihuana could affect seizure activity in epileptic patients, as well as interact with clinically used antiepileptic drugs (10 
